2021
DOI: 10.1038/s41598-021-90643-3
|View full text |Cite
|
Sign up to set email alerts
|

Pronounced proliferation of non-beta cells in response to beta-cell mitogens in isolated human islets of Langerhans

Abstract: The potential to treat diabetes by increasing beta-cell mass is driving a major effort to identify beta-cell mitogens. Demonstration of mitogen activity in human beta cells is frequently performed in ex vivo assays. However, reported disparities in the efficacy of beta-cell mitogens led us to investigate the sources of this variability. We studied 35 male (23) and female (12) human islet batches covering a range of donor ages and BMI. Islets were kept intact or dispersed into single cells and cultured in the p… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 42 publications
2
6
0
Order By: Relevance
“…Harmine also efficiently induced b-cell proliferation in our platform, with quite low donor-to-donor variation. The observed proliferative rates identified based on the quantification of EdU and NKX6.1 were within a similar range to those previously reported (32,33,36,37,53,54). Our data also confirmed the non-specificity of harmine: we and others have found that harmine induces high levels of proliferation of non-b-cells (32,36,37,53), although this has been suggested to be rectified through combinatorial treatment with GLP-1 receptor agonists (32).…”
Section: Discussionsupporting
confidence: 91%
See 2 more Smart Citations
“…Harmine also efficiently induced b-cell proliferation in our platform, with quite low donor-to-donor variation. The observed proliferative rates identified based on the quantification of EdU and NKX6.1 were within a similar range to those previously reported (32,33,36,37,53,54). Our data also confirmed the non-specificity of harmine: we and others have found that harmine induces high levels of proliferation of non-b-cells (32,36,37,53), although this has been suggested to be rectified through combinatorial treatment with GLP-1 receptor agonists (32).…”
Section: Discussionsupporting
confidence: 91%
“…The observed proliferative rates identified based on the quantification of EdU and NKX6.1 were within a similar range to those previously reported ( 32 , 33 , 36 , 37 , 53 , 54 ). Our data also confirmed the non-specificity of harmine: we and others have found that harmine induces high levels of proliferation of non-β-cells ( 32 , 36 , 37 , 53 ), although this has been suggested to be rectified through combinatorial treatment with GLP-1 receptor agonists ( 32 ). Perplexingly, one of the most interesting observations we made was the significantly increased β-cell count and fraction with high harmine dose treatment, despite low β-cell and high non-β-cell proliferation rates.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…Following treatment, islets were dissociated into single cells with accutase (1 μL/islet; Innovative Cell Technologies Inc.) for 10 minutes at 37°C, and β cell proliferation was assessed by flow cytometry as described previously ( 76 ). Dead cells were labeled using the LIVE/DEAD Aqua (405 nm) (BD Bioscience).…”
Section: Methodsmentioning
confidence: 99%
“…Following treatment islets were dissociated into single cells with accutase (1 μl/islet; Innovative Cell Technologies Inc., San Diego, CA) for 10 min at 37° and β-cell proliferation assessed by flow cytometry as described previously (66). Dead cells were labeled using the LIVE/DEAD™ Aqua (405 nm) (BD Bioscience).…”
Section: Methodsmentioning
confidence: 99%